Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2024 third quarter earnings
what-you-need-to-know-about-johnson-johnsons-2024-third-quarter-earnings-1024.png

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

This morning, Johnson & Johnson shared its 2024 third quarter earnings report.

Since its founding in 1886 the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.

“Johnson & Johnson’s performance in the third quarter reflects the diversification of our business and forward-looking, disciplined approach as we continue to invest in breakthrough innovation and acquisitions such as V-Wave that further bolster and differentiate our pipeline,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we wind down 2024, we are focused on advancing our pipeline further, positioning the business for continued growth in 2025 and beyond.”

For more details about the company’s 2024 third quarter results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

2024-third-quarter-earnings-infographic-1024.png

Johnson & Johnson’s 2024 third quarter earnings

Read the earnings press release, which includes full financial data for the third quarter of 2024.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.